Kerala Govt Unveils Master Plan for Idukki’s Medical College Hospital

Kerala- In a pivotal meeting convened by Kerala Health Minister Veena George and Water Resources Minister Roshi Augustine recently, a significant advancement in healthcare at the Government Medical College Hospital (MCH) in Idukki, Kerala, was announced.

The announcement calls for expediting steps to acquire 50 acres of land earmarked for the expansion plans of MCH and subsequently handing it over to the Directorate of Medical Education, along with the District Collector, ensuring soil testing and all ancillary and mandatory investigations.

Besides, cutting-edge facilities like modular operation theatres will be incorporated with the funding of ₹1.5 crores from the MP fund, which will later be handed over to the Kerala Medical Services Corporation.

However, construction is underway for the women’s hostel, compound wall, streetlights, and installation of an 11-kV feeder line which is expected to be completed within a month. Furthermore, plans for solid waste disposal and the construction of a new block for a nursing college are also included.

Speaking to The Hindu, Ms George in her statement has said that “a Special Purpose Vehicle would be created for the preparation of the master plan”.

“The attendance of medical faculty as well as non-faculty staff be ensured in the institution”, Ms George further added in her statement.

Meanwhile, Mr Augustine stated that “the construction of the road from the Cheruthioni bus stand to the MCH be commenced immediately. The civil, mechanical and electrical works in the new block of the hospital will be taken up soon”.

The meeting was also headed by the Principal Secretary (Health), State Mission Directors of the National Health Mission, the Director of Medical Education, the Director of Health Services and other senior health officials.

The Master Plan of the Government of Kerala will enhance both the infrastructure requirements and the standard of medical services in the region.

Powered by WPeMatico

Pre-natal sex determination racket exposed, 3 held

In a significant breakthrough, police teams from Ghaziabad and Sonipat exposed a pre-natal sex determination racket operating within the premises of Shiva Ultrasound, a registered centre in Ghaziabad.

The accused had allegedly been facilitating couples from Haryana and neighbouring states for illicit sex determination tests, charging a hefty fee of Rs 30,000.

For more information click on the link below:

Powered by WPeMatico

Fake drugs racket busted in Uttarakhand

Two people were arrested here on Thursday and a consignment of spurious drugs worth Rs 43 lakh was seized from them by a team of Telangana Police, officials said.

Those arrested include the owner of the factory where the medicines were manufactured, Hyderabad’s Drugs Inspector Kiran Kumar Jannu, who accompanied a four-member Telangana Police team to Kotdwar, told PTI.
For more information click on the link below:

Powered by WPeMatico

Consumer Court absolves Max Hospital, Cardio-Diabetologist of medical negligence over alleged delay in treatment

The Delhi state consumer disputes redressal commission has absolved Max Super Speciality Hospital, a senior consultant physician & cardio-diabetologist and others in a case alleging medical negligence over the delay in admitting a patient and not providing timely medical treatment resulting in paralysis on the left side of his body and ongoing seizures.

The commission, led by Justice Sangita Dhingra Sehgal delivered the decision on 12th January 2024 noting that the complainant failed to establish negligence or deficiency in service on the part of Max Super Speciality Hospital and no lackadaisical approach of the treating doctors were found.

For more information click on the link below:

Powered by WPeMatico

NPPA Fixes Ceiling Price Of 6 Scheduled Formulations, Details

New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of 6 scheduled formulations under the Drugs (Prices Control) Order, 2013 (NLEM 2022).

The list includes the combination drug Darunavir (600mg) plus Ritonavir (100mg), Nicotine (for nicotine replacement therapy), Levonorgestrel, Cholecalciferol, and the combination drug Tenofovir Disproxil Fumarate plus Lamivudine plus Dolutegravir.

Scheduled formulation means any formulation, included in the First Schedule whether referred to by generic versions or brand names (mainly products covered under the National List of Essential Medicines are Scheduled Formulation). In other words, all medicines that are covered in the National List of Essential Medicine, which are notified in Schedule 1, by the Govt. are scheduled formulation.

“Ceiling Price” refers to a price fixed by the Government for Scheduled Formulations in accordance with the provisions of the drugs (prices control) order, 2013. The ceiling Price is the Maximum Price to Retailer (excluding Taxes, if any)for the given product.

The notice further in the exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17, and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated 30th May 2013 and S.O. 5249(E) dated 11th November 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) has fixed the prices as specified in column (5) of the table herein below as ceiling price exclusive of Goods and Services Tax applicable, if any, in respect of the Scheduled formulation specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:

Sl.

No.

Name of the Scheduled Formulation

Dosage form and strength

Unit

Ceiling

Price (Rs.)

(1)

(2)

(3)

(4)

(5)

1

Darunavir (A) +Ritonavir (B)

Tablet 600mg (A) + 100mg (B)

1 Tablet

146.45

2

Nicotine (for nicotine replacement therapy)

Oral Dosage forms 2mg Pastille

1 Pastille

7.12

3

Nicotine (for nicotine replacement therapy)

Oral Dosage forms 4mg Pastille

1 Pastille

7.83

4

Levonorgestrel

Tablet 1.5mg

1 Tablet

75.35

5

Cholecalciferol

Solid oral dosage form 1000 IU

Sachet/Granuels/Powder

1 Gram

23.14

6

Tenofovir Disproxil

Fumarate + Lamivudine + Dolutegravir

Tablet 300mg + 300mg + 50 mg

1 Tablet

114.98

The notification further added,

(j) All manufacturers of scheduled formulation, selling the branded or generic or both versions of scheduled formulations at a price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.

(k) All the existing manufacturers of the above-mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.

(l) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above-said table.

(m) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from the date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to the State Drug Controller and dealers.

(n) As per para 24(4) of DPCO 2013, every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(o) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2(1)(u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.

(p) The manufacturers of the above-said scheduled formulations shall furnish a quarterly returns to the NPPA, in respect of production/import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.

(q) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.

(r) Consequent to the issue of the ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above-said date of notification, stand(s) superseded.

Powered by WPeMatico

Mohali’s Dr BR Ambedkar State Institute of Medical Sciences to get 6 bedded ICU soon

Mohali: To ensure that critical patients get the best treatment at nominal charges, Punjab Health and Family Welfare Minister Dr Balbir Singh on Friday announced that Dr BR Ambedkar State Institute of Medical Sciences (AIMS) Mohali is all set to get a 6-bedded medical ICU as a part of the ongoing Sehatmand Punjab Mission. 

During his visit to AIMS Mohali, he stated that Chief Minister Bhagwant Mann will be inaugurating the new ICU facility that will offer advanced medical care to patients at a reasonable price.

Dr Singh said that the ICU is operational and ready to take critical patients with all life-saving equipment like crash carts, patient monitors, defibrillators and infusion pumps along with ventilators.

Also read- PM Modi To Inaugurate 250-Bed IPD At AIIMS Rajkot On February 25

Terming it as a significant milestone in the journey toward advancing healthcare excellence, the Health Minister said that this initiative will strengthen the medical infrastructure of the state.

The Health Minister also visited the newly constructed state-of-the-art Biosafety Level 2 Lab at AIMS Mohali. He said that the purpose of this lab is to cater to the community and help in the timely identification of viruses of public health significance at the molecular level like like influenza virus and other viruses causing respiratory tract infections, vector-borne viruses including dengue, chikungunya, Zika and viruses causing GI infections including hepatitis virus, sexually transmitted infections like Human papillomavirus and viruses causing CNS infections. 

This fully equipped lab has advanced infrastructure and the latest equipment including Biosafety cabinets, RNA extractor, Refrigerated centrifuge, vortex mixers, mini-spinners, thermo-shakers, pipettes, Autoclave, PCR workstations, -40 degree and -80 degree Celsius deep freezers, RTPCR machines, computer units with printers and all the required consumables as reported by the Punjab Newsline.

The health minister accompanied by the director-principal of AIMS Mohali Dr Bhavneet Bharti, Superintendent Dr Navdeep Singh Saini, and SMOs Dr HS Cheema and Dr Vijay Bhagat, assessed the readiness of the ICU.

Punjab Chief Minister Bhagwant Mann, along with his Delhi counterpart Arvind Kejriwal, launched the ambitious ‘Sehatmand Punjab’ Mission worth Rs 550 crore aiming at enhancing the well-being of the people of Punjab and elevating the state’s healthcare infrastructure.

Also read- Punjab Govt Plans To Set Up 2 Medical Colleges In Moga, Khatkar Kalan

Powered by WPeMatico

Health Bulletin 02/ March/ 2024

Here are the Top Health stories for the day:

Court clears hospital and doctor of negligence

The Delhi state consumer disputes redressal commission has absolved Max Super Speciality Hospital, a senior consultant physician & cardio-diabetologist and others in a case alleging medical negligence over the delay in admitting a patient and not providing timely medical treatment resulting in paralysis on the left side of his body and ongoing seizures.

The commission, led by Justice Sangita Dhingra Sehgal delivered the decision on 12th January 2024 noting that the complainant failed to establish negligence or deficiency in service on the part of Max Super Speciality Hospital and no lackadaisical approach of the treating doctors were found.

For more information click on the link below:


Illegal sex determination ring busted

In a significant breakthrough, police teams from Ghaziabad and Sonipat exposed a pre-natal sex determination racket operating within the premises of Shiva Ultrasound, a registered centre in Ghaziabad.

The accused had allegedly been facilitating couples from Haryana and neighbouring states for illicit sex determination tests, charging a hefty fee of Rs 30,000.

For more information click on the link below:

Consignment of spurious drugs worth Rs 43 lakh seized, 2 held

Two people were arrested here on Thursday and a consignment of spurious drugs worth Rs 43 lakh was seized from them by a team of Telangana Police, officials said.
Those arrested include the owner of the factory where the medicines were manufactured, Hyderabad’s Drugs Inspector Kiran Kumar Jannu, who accompanied a four-member Telangana Police team to Kotdwar, told PTI.
For more information click on the link below:

Powered by WPeMatico

Yoga, Blood Pressure Management and Its Evidence from Trials – Dr Indranill Basu Ray

Yoga, a holistic mind-body discipline, is gaining recognition for its role in the management of hypertension (HTN), a widespread health challenge characterized by elevated blood pressure levels. This condition, if left unmanaged, can lead to critical health complications.
The multifaceted approach of yoga, incorporating physical postures, breath control techniques, and meditation, offers a promising avenue for blood pressure (BP) regulation. As a complementary strategy alongside lifestyle changes and medical treatments, yoga offers a non-drug approach to mitigating the risks associated with high blood pressure.
The global health community is increasingly exploring the long-term benefits of yoga as part of a comprehensive strategy for hypertension management, emphasizing the importance of integrating lifestyle modifications for optimal health outcomes.
Research on yoga’s role in managing hypertension reveals its potential as a supportive therapy, capable of lowering both systolic and diastolic blood pressure in individuals with elevated levels.
This body of evidence, encompassing systematic reviews and randomized controlled trials (RCTs), suggests that yoga may offer significant benefits in blood pressure management when implemented alongside standard care or in the absence of other treatments, although its advantages over certain interventions like pharmacotherapy or conventional exercise vary.
The efficacy of yoga in blood pressure reduction appears to depend on the specifics of the yoga practice, with programs that integrate a broader spectrum of yoga elements—such as physical postures, meditation, and breathe control—tending to yield more pronounced benefits.
However, not all studies find yoga to outperform other lifestyle interventions, highlighting the need for further research to clarify its unique contributions to hypertension management.
Yoga’s potential to be incorporated into routine primary healthcare for hypertension has been demonstrated, particularly through interventions led by health professionals. These programs have shown success in reducing blood pressure, suggesting a practical model for yoga’s integration into broader health strategies.
The physiological mechanisms underlying yoga’s impact on blood pressure involve the modulation of stress responses, enhancement of parasympathetic nervous system activity, and adjustments in baroreceptor sensitivity. Evidence points towards the calming effect of yoga on the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis as key factors in its efficacy.
Despite the heterogeneity in yoga practices and the varying quality of research, there is a consensus that yoga can be beneficial for both normotensive and hypertensive individuals.
Yet, due to this variability, specific yoga recommendations for hypertension treatment remain to be determined.
Yoga interventions that emphasize breathing and meditation, especially when practiced regularly, are linked with greater reductions in blood pressure. Such practices, particularly Hatha yoga, have been found beneficial across different age groups, with meditation showing notable effectiveness in older adults and yoga in younger populations.
Beyond blood pressure control, yoga has been associated with improvements in other cardiovascular health markers, mental health, and overall quality of life, underscoring its value as a multifaceted intervention for hypertension.
Notably, yoga therapy, when combined with dietary changes or biofeedback, has demonstrated enhanced effectiveness, further supporting its role as a comprehensive and complementary treatment option without adverse effects.
Yoga presents a promising adjunct therapy for hypertension, characterized by its ability to lower blood pressure and improve general health, the need for more rigorous and conclusive research remains to delineate its full potential and optimal application in hypertension care.
The compilation of studies suggests yoga as an effective supplementary approach for blood pressure reduction among individuals with hypertension. It appears that the most significant advantages are linked to a holistic yoga regimen that incorporates physical postures, breathing techniques, and meditation or mental relaxation, especially with regular practice.
Despite supportive evidence for yoga’s role in lowering blood pressure, there remains a need for further high-caliber research to identify the yoga practices most beneficial for hypertension care.
Yoga offers a non-medical strategy for hypertension management, with research indicating its potential in decreasing both systolic and diastolic blood pressure levels. The integration of breathing exercises and meditation/mental relaxation within yoga routines may amplify its anti-hypertensive benefits.
While practicing yoga alone has its merits, augmenting it with additional lifestyle adjustments, such as improved nutrition, can lead to more substantial reductions in blood pressure. Current research advocates for incorporating yoga into clinical hypertension treatment guidelines, promoting a comprehensive approach that emphasizes treating the individual holistically.

Disclaimer: The views expressed in this article are of the author and not of Medical Dialogues. The Editorial/Content team of Medical Dialogues has not contributed to the writing/editing/packaging of this article.

Powered by WPeMatico

An overgrowth of nerve cells appears to cause lingering symptoms after recurrent UTIs

A perplexing problem for people with recurring urinary tract infections (UTIs) is persistent pain, even after antibiotics have successfully cleared the bacteria.

Powered by WPeMatico

Large-scale study explores link between smoking and DNA changes across six racial and ethnic groups

Smoking changes the way genes are expressed, which later contributes to the development of lung cancer and other smoking-related illnesses. But the link between epigenetics (the study of mechanisms that impact gene expression) and smoking is not fully understood, especially in terms of differences across racial and ethnic groups.

Powered by WPeMatico